Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1273% % 14%
Debt-to-equity 18% % -2.9%
Return On Equity -39% % -49%
Return On Assets -33% % -50%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74,337,990 shares 10%
Common Stock, Shares, Outstanding 74,337,990 shares 10%
Common Stock, Value, Issued $74,000 USD 10%
Weighted Average Number of Shares Outstanding, Basic 74,296,000 shares 5.2%
Weighted Average Number of Shares Outstanding, Diluted 74,296,000 shares 5.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $64,174,000 USD 79%
General and Administrative Expense $31,528,000 USD 35%
Operating Income (Loss) $118,716,000 USD -106%
Nonoperating Income (Expense) $10,305,000 USD 33%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $108,411,000 USD -118%
Net Income (Loss) Attributable to Parent $105,800,000 USD -66%
Earnings Per Share, Basic -1 USD/shares 8.1%
Earnings Per Share, Diluted -1 USD/shares 8.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $26,762,000 USD -88%
Cash, Cash Equivalents, and Short-term Investments $174,100,000 USD -35%
Accounts Receivable, after Allowance for Credit Loss, Current $179,000 USD -18%
Other Assets, Current $81,000 USD 80%
Assets, Current $178,500,000 USD -34%
Property, Plant and Equipment, Net $64,351,000 USD 47%
Operating Lease, Right-of-Use Asset $1,536,000 USD -37%
Intangible Assets, Net (Excluding Goodwill) $279,000 USD -21%
Goodwill $0 USD -100%
Other Assets, Noncurrent $438,000 USD -37%
Assets $294,825,000 USD -25%
Employee-related Liabilities, Current $6,711,000 USD 69%
Liabilities, Current $20,618,000 USD -27%
Deferred Income Tax Liabilities, Net $2,495,000 USD -46%
Operating Lease, Liability, Noncurrent $971,000 USD -42%
Other Liabilities, Noncurrent $342,000 USD 936%
Liabilities $52,609,000 USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $114,000 USD
Retained Earnings (Accumulated Deficit) $297,350,000 USD -55%
Stockholders' Equity Attributable to Parent $242,216,000 USD -26%
Liabilities and Equity $294,825,000 USD -25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $21,582,000 USD -256%
Net Cash Provided by (Used in) Financing Activities $9,973,000 USD -94%
Net Cash Provided by (Used in) Investing Activities $5,565,000 USD 88%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 74,337,990 shares 10%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $17,174,000 USD -113%
Deferred Tax Assets, Valuation Allowance $41,830,000 USD 40%
Deferred Tax Assets, Gross $50,834,000 USD 31%
Operating Lease, Liability $1,675,000 USD -35%
Depreciation $346,000 USD 92%
Payments to Acquire Property, Plant, and Equipment $4,656,000 USD -49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $105,686,000 USD -71%
Lessee, Operating Lease, Liability, to be Paid $1,863,000 USD -37%
Property, Plant and Equipment, Gross $69,546,000 USD 51%
Operating Lease, Liability, Current $704,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Two $493,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year One $647,000 USD -42%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $2,097,000 USD 21%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $188,000 USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year Three $443,000 USD -10%
Deferred Tax Assets, Operating Loss Carryforwards $35,307,000 USD 32%
Preferred Stock, Shares Authorized 7,000,000 shares 0%
Unrecognized Tax Benefits $526,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $443,000 USD 93%
Deferred Tax Assets, Net of Valuation Allowance $9,004,000 USD 1.5%
Share-based Payment Arrangement, Expense $8,717,000 USD 126%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%